Search images on Google      Product Monograph

Active Ingredients:

• lumasiran (lumasiran sodium), 94.5 MG/0.5 ML

DIN: 02525755

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: ALNYLAM NETHERLANDS B.V.

ATC:

• A16 - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, WHO, Wiki)
• A16A - OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, WHO)
• A16AX - Various alimentary tract and metabolism products (ATC, WHO)
• A16AX18 - LUMASIRAN (WHO)

 

External Links for Oxlumo:

Search on Google

• Oxlumo side effects
• Oxlumo dosage
• lumasiran side effects
• lumasiran dosage